entertainment -WSS

entertainment

author：explore 2025-09-05 15:43:06 - browse：8

Adobe

WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： How Medicaid coverage policies for immigrants impact new moms

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

EpiPen alternative approval delay highlights citizen petition issue

Senate HELP committee spars over health care workforce policies

Sanders adds drug shortage policies to pandemic preparedness bill

Experts study whether long Covid risk adds up with each reinfection

What Congress can do to address the rural doctor shortage

hotspot

entertainment

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Thermo Fisher plant for manufacturing gene therapies to expand

Medical leaders decry Supreme Court decision on affirmative action

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Hepatitis C has a cure — but many Americans still lack access to it

STAT Virtual Event: The State of Biosimilars: What to Watch

Medicare proposal to cover medical devices draws a mixed reaction

Thermo Fisher plant for manufacturing gene therapies to expand

Apple is now the first public company to be valued at $3 trillion

STAT Virtual Event: The State of Biosimilars: What to Watch

explore

Key House panel plots a new health care package

CommonSpirit Health keeps growing, even as it loses money

AI can’t replace a physician’s gut feeling

Medicare to cover more brain scans for Alzheimer’s patients

Thermo Fisher plant for manufacturing gene therapies to expand

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

focus

entertainment

explore

Wikipedia